Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases.

MLA

Spyrakis, Francesca, et al. “Virtual Screening Identifies Broad-Spectrum β-Lactamase Inhibitors with Activity on Clinically Relevant Serine- and Metallo-Carbapenemases.” Scientific Reports, vol. 10, no. 1, July 2020, p. 12763. EBSCOhost, https://doi.org/10.1038/s41598-020-69431-y.

APA

Spyrakis, F., Santucci, M., Maso, L., Cross, S., Gianquinto, E., Sannio, F., Verdirosa, F., De Luca, F., Docquier, J.-D., Cendron, L., Tondi, D., Venturelli, A., Cruciani, G., & Costi, M. P. (2020). Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases. Scientific Reports, 10(1), 12763. https://doi.org/10.1038/s41598-020-69431-y

Chicago

Spyrakis, Francesca, Matteo Santucci, Lorenzo Maso, Simon Cross, Eleonora Gianquinto, Filomena Sannio, Federica Verdirosa, et al. 2020. “Virtual Screening Identifies Broad-Spectrum β-Lactamase Inhibitors with Activity on Clinically Relevant Serine- and Metallo-Carbapenemases.” Scientific Reports 10 (1): 12763. doi:10.1038/s41598-020-69431-y.